Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Cynosure Group LLC

Cynosure Group LLC reduced its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 21.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,955 shares of the biotechnology company’s stock after selling 521 shares during the period. Cynosure Group LLC’s holdings in Axon Enterprise were worth $781,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Trust Inc. grew its stake in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC lifted its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the last quarter. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $41,000. Asset Dedication LLC bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $47,000. Finally, Planning Capital Management Corp raised its position in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on AXON shares. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. JMP Securities boosted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird increased their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Craig Hallum lifted their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, Needham & Company LLC increased their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $427.83.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 75,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total value of $26,739,750.00. Following the completion of the sale, the chief executive officer now directly owns 2,970,366 shares of the company’s stock, valued at approximately $1,059,024,589.98. This represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Brittany Bagley sold 4,338 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the transaction, the chief financial officer now owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. This trade represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 260,256 shares of company stock valued at $105,984,120. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Performance

AXON stock opened at $632.16 on Wednesday. The company has a market capitalization of $48.20 billion, a P/E ratio of 163.35, a PEG ratio of 13.62 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a 50-day simple moving average of $468.24 and a 200 day simple moving average of $370.65. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $641.20.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.